CHARLOTTE, N.C. (Legal Newsline) - For weeks during the bankruptcy trial of Garlock Sealing Technologies, lawyers representing the manufacturer called former attorneys who represented the company and other witnesses to testify about what they allege were underhandedness and fraud on the part of plaintiff attorneys in asbestos-related lawsuits.
CHARLOTTE, N.C. (Legal Newsline) -- After more than three weeks of testimony with expert witnesses and lawyers flown in from across the country, the bankruptcy trial for Garlock Sealing Technologies concluded Thursday with one glaring question left unanswered - just how much money the company sued for making asbestos-containing products decades ago will need to put in a trust to escape bankruptcy.
CHARLOTTE, N.C. (Legal Newsline) - Attorneys for Legal Newsline have appealed a U.S. bankruptcy court judge's decision to close off testimony and portions of the record of several witnesses speaking about questionable claims filed by asbestos plaintiffs during the ongoing bankruptcy trial for Garlock Sealing Technologies.
CHARLOTTE, N.C. (Legal Newsline) -- The ongoing bankruptcy trial for Garlock Sealing Technologies wound down Monday with attorneys for the gasket manufacturing company and those representing asbestos claimants calling their last few witnesses with the judge closing the courtroom one more time during a lawyer's testimony.
CHARLOTTE, N.C. (Legal Newsline) -- Attorneys transitioned Friday from days of expert testimony on the carcinogenic effects of asbestos and the work practices of attorneys representing asbestos plaintiffs to arguments about how much financial liability Garlock Sealing Technologies should face in the company's ongoing bankruptcy trial.
CHARLOTTE, N.C. (Legal Newsline) -- The closed testimony of a former Garlock Sealing Technologies attorney resumed Thursday with the judge excluding members of the public and media who did not sign confidentiality agreements for all but 20 minutes of his nearly five hours on the stand in the company's ongoing bankruptcy trial.